Citations 44

Binocular Interference vs Diplopia in Patients With Epiretinal Membrane

JAMA Ophthalmology | September 10, 2020 | Volume: 138 | Issue: 11 | Pages: 1121

10.1001/jamaophthalmol.2020.3328 | PMID 32910144

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity

JAMA Ophthalmology | April 23, 2020 | Volume: 138 | Issue: 6 | Pages: 698

10.1001/jamaophthalmol.2020.0334 | PMID 32324197

Association of Strabismus With Functional Vision and Eye-Related Quality of Life in Children

JAMA Ophthalmology | March 26, 2020 | Volume: 138 | Issue: 5 | Pages: 528

10.1001/jamaophthalmol.2020.0539 | PMID 32215586

Three‐year observation of children 12 to 35 months old with untreated intermittent exotropia

Ophthalmic and Physiological Optics | March 23, 2020 | Volume: 40 | Issue: 2 | Pages: 202-215

10.1111/opo.12668 | PMID 32202318

Abstract Purpose To describe the clinical course of untreated intermittent exotropia (IXT) in children 12–35 months of age followed for 3 years. Methods We enrolled 97 children 12–35 months of age with previously untreated IXT who had been randomly assigned to the observation arm of a randomised trial of short‐term occlusion versus observation. Participants were observed unless deterioration criteria were met at a follow‐up visit occurring at 3 months, 6 months, and 6‐month intervals thereafter for 3 years. The primary outcome was deterioration of the IXT by 3 years, defined as (1) a constant exotropia ≥10 prism dioptres (∆) at distance and near (i.e., motor deterioration) or (2) treatment prescribed despite not having met motor deterioration. The primary analysis used the Kaplan‐Meier method to determine the cumulative proportion of participants meeting deterioration by three years and 95% confidence interval (CI). Results The cumulative probability of deterioration by 3 years was 28% (95% CI = 20%–39%). Of the 24 participants meeting the primary outcome of deterioration, seven met motor deterioration and 17 were prescribed treatment without meeting motor deterioration. The cumulative probability of motor deterioration by 3 years was 10% (95% CI = 5%–19%). Conclusions Given the modest rate of motor deterioration over three years, watchful waiting may be a reasonable management approach in 12‐ to 35‐month‐old children with IXT. To confirm this recommendation would require a long‐term randomised trial of immediate treatment versus observation followed by deferred treatment if needed.
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity

JAMA Ophthalmology | November 7, 2019 | Volume: 138 | Issue: 1 | Pages: 14

10.1001/jamaophthalmol.2019.4488 | PMID 31697304

New Onset vs Resolution of Central-Peripheral Rivalry–Type Diplopia in Patients Undergoing Epiretinal Membrane Peeling

JAMA Ophthalmology | December 13, 2018 | Volume: 137 | Issue: 3 | Pages: 293

10.1001/jamaophthalmol.2018.6042 | PMID 30543335

Factors Associated With Health-Related Quality of Life in Medically and Surgically Treated Patients With Glaucoma

JAMA Ophthalmology | February 22, 2018 | Volume: 136 | Issue: 4 | Pages: 348

10.1001/jamaophthalmol.2018.0012 | PMID 29470573

Role of a Standardized Prism Under Cover Test in the Assessment of Dissociated Vertical Deviation

Strabismus | February 2, 2018 | Volume: 26 | Issue: 1 | Pages: 1-5

10.1080/09273972.2017.1391850 | PMID 29393712

Lessons From Recent Randomized Clinical Trials of Binocular Treatment for Amblyopia

JAMA Ophthalmology | January 4, 2018 | Volume: 136 | Issue: 2 | Pages: 181

10.1001/jamaophthalmol.2017.5938 | PMID 29302679

Factors Associated With Failure of Adult Strabismus–20 Questionnaire Scores to Improve Following Strabismus Surgery

JAMA Ophthalmology | November 22, 2017 | Volume: 136 | Issue: 1 | Pages: 46

10.1001/jamaophthalmol.2017.5088 | PMID 29167898